Medicare Enrolled
Dr. Scott Tetreault, M.D.
Medical Oncology · Tallahassee, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tetreault from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tetreault?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tetreault
Dr. Scott Tetreault is a medical oncology specialist in Tallahassee, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tetreault performed 75,107 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Tetreault received a total of $16,024 from 94 pharmaceutical and/or device companies across 946 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tetreault is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 30% volume in FL
$16,024 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗75,107
Medicare services
Top 30% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
19,400 | $0 | $5 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,280 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 11,000 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
8,221 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 7,150 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,660 | $19 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,964 | $0 | $3 |
| Iron infusion (Monoferric) | 2,000 | $17 | $57 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,232 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,031 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 740 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 512 | $0 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
350 | $10 | $69 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
349 | $97 | $378 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
309 | $12 | $61 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
264 | $21 | $84 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
242 | $94 | $339 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
218 | $47 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
204 | $63 | $239 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
162 | $1 | $3 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
125 | $4 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
94 | $22 | $79 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
83 | $49 | $178 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
76 | $23 | $89 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
70 | $136 | $474 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
67 | $3 | $11 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
55 | $28 | $156 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
45 | $18 | $59 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
43 | $1 | $6 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
28 | $15 | $56 |
| New patient office visit, complex (60-74 min) | 24 | $172 | $585 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
23 | $2 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $115 | $453 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
17 | $10 | $42 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
17 | $2 | $7 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
15 | $1 | $7 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $137 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
23.0% high complexity
73.0% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,024
Total received (2018-2024)
Avg $2,289/year across 7 years
Top 32% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
94
Companies
946
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,998
2023
$2,269
2022
$2,460
2021
$2,490
2020
$1,969
2019
$2,458
2018
$2,380
Payments by company (2024)
Ipsen Biopharmaceuticals, Inc
$203
Celgene Corporation
$188
Merck Sharp & Dohme LLC
$173
E.R. Squibb & Sons, L.L.C.
$170
AstraZeneca Pharmaceuticals LP
$129
Gilead Sciences, Inc.
$87
ABBVIE INC.
$76
Daiichi Sankyo Inc.
$75
Eisai Inc.
$67
Astellas Pharma US Inc
$62
JAZZ PHARMACEUTICALS INC.
$61
Incyte Corporation
$55
Novartis Pharmaceuticals Corporation
$55
Lilly USA, LLC
$53
GlaxoSmithKline, LLC.
$46
TAIHO ONCOLOGY, INC.
$40
Pharmacosmos Therapeutics Inc.
$39
Genentech USA, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$31
Genmab U.S., Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Novocure Inc.
$28
Stemline Therapeutics Inc.
$26
Kyowa Kirin, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
GENZYME CORPORATION
$19
Exelixis Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$17
Aveo Pharmaceuticals, Inc.
$17
ARRAY BIOPHARMA INC
$16
SERVIER PHARMACEUTICALS LLC
$16
Alnylam Pharmaceuticals Inc.
$16
Alexion Pharmaceuticals, Inc.
$16
SOBI, INC
$15
Mirati Therapeutics, Inc.
$13
Sirtex Medical Inc
$7
Rigel Pharmaceuticals, Inc.
$6
Top 3 companies account for 28.2% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,738
Amgen Inc.
$1,208
Celgene Corporation
$1,022
AstraZeneca Pharmaceuticals LP
$982
Novartis Pharmaceuticals Corporation
$630
GENZYME CORPORATION
$548
Genentech USA, Inc.
$526
Merck Sharp & Dohme Corporation
$524
Ipsen Biopharmaceuticals, Inc
$508
Merck Sharp & Dohme LLC
$498
Daiichi Sankyo Inc.
$417
Seagen Inc.
$395
Gilead Sciences, Inc.
$361
PFIZER INC.
$357
Lilly USA, LLC
$343
GlaxoSmithKline, LLC.
$310
Eisai Inc.
$309
Astellas Pharma US Inc
$296
Janssen Biotech, Inc.
$283
Takeda Pharmaceuticals U.S.A., Inc.
$250
Regeneron Healthcare Solutions, Inc.
$207
Octapharma USA, Inc.
$204
Alexion Pharmaceuticals, Inc.
$203
Incyte Corporation
$203
Bayer HealthCare Pharmaceuticals Inc.
$201
Exelixis Inc.
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$166
TESARO, Inc.
$145
JAZZ PHARMACEUTICALS INC.
$143
AbbVie Inc.
$132
Seattle Genetics, Inc.
$124
Foundation Medicine, Inc.
$117
ABBVIE INC.
$111
SANOFI-AVENTIS U.S. LLC
$98
Taiho Oncology, Inc.
$94
Lexicon Pharmaceuticals, Inc.
$93
Agios Pharmaceuticals, Inc.
$92
ARRAY BIOPHARMA INC
$82
AMAG Pharmaceuticals, Inc.
$80
Stemline Therapeutics Inc.
$78
TerSera Therapeutics LLC
$78
Pharmacosmos Therapeutics Inc.
$64
EMD Serono, Inc.
$60
Rigel Pharmaceuticals, Inc.
$58
TAIHO ONCOLOGY, INC.
$57
Karyopharm Therapeutics Inc.
$56
G1 Therapeutics, Inc.
$55
CSL Behring
$55
MorphoSys, US Inc.
$54
Emmaus Medical, Inc.
$52
BeiGene USA, Inc.
$49
Sysmex Inostics Inc
$45
INSYS Therapeutics Inc
$45
PUMA BIOTECHNOLOGY, INC.
$43
EISAI INC.
$40
Bayer Healthcare Pharmaceuticals Inc.
$40
Pharmacyclics LLC, an AbbVie Company
$39
Heron Therapeutics, Inc.
$37
ADC Therapeutics America, Inc.
$34
Kyowa Kirin, Inc.
$34
Jazz Pharmaceuticals Inc.
$33
SOBI, INC
$33
Aveo Pharmaceuticals, Inc.
$32
Alnylam Pharmaceuticals Inc.
$31
Dendreon Pharmaceuticals LLC
$30
MEDIVATION FIELD SOLUTIONS LLC
$30
Genmab U.S., Inc.
$30
Dova Pharmaceuticals
$29
SERVIER PHARMACEUTICALS LLC
$29
Coherus Biosciences Inc.
$29
Blueprint Medicines Corporation
$29
Kite Pharma, Inc.
$28
Novocure Inc.
$28
Global Blood Therapeutics, Inc.
$28
Mirati Therapeutics, Inc.
$28
Myovant Sciences Inc.
$26
Acrotech Biopharma LLC
$25
Janssen Pharmaceuticals, Inc
$25
Clovis Oncology, Inc.
$22
Array BioPharma Inc.
$21
ImmunoGen, Inc.
$20
CTI BioPharma Corp.
$18
Pharmacyclics LLC, An AbbVie Company
$18
TG THERAPEUTICS, INC.
$17
Horizon Therapeutics plc
$17
TOLMAR Pharmaceuticals, Inc.
$15
Apellis Pharmaceuticals, Inc.
$14
AbbVie, Inc.
$14
Puma Biotechnology, Inc.
$14
Verastem, Inc.
$14
Servier Pharmaceuticals LLC
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
TG Therapeutics, Inc.
$12
Sirtex Medical Inc
$7
Top 3 companies account for 24.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Cinvanti · Cometriq · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ERLEADA · EVENITY · Elahere · Endari · Enhertu · Epkinly · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · HYQVIA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Inrebic · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · Poteligeo · Prolia · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$65,074
Nearest hospital to ZIP centroid (approximate)
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tetreault is a mixed practice specialist, with above-average Medicare volume (top 30% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tetreault experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Tetreault performed 19,400 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Tetreault receive payments from pharmaceutical companies?
Yes. Dr. Tetreault received a total of $16,024 from 94 companies across 946 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tetreault's costs compare to other medical oncologists in Tallahassee?
Dr. Tetreault's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tetreault) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Tallahassee
Browse medical oncologists in Tallahassee ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology